GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NeutriSci International Inc (OTCPK:NRXCF) » Definitions » Capex-to-Operating-Income

NeutriSci International (NeutriSci International) Capex-to-Operating-Income : 0.00 (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is NeutriSci International Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

NeutriSci International's Capital Expenditure for the three months ended in Sep. 2023 was $0.00 Mil. Its Operating Income for the three months ended in Sep. 2023 was $-0.07 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


NeutriSci International Capex-to-Operating-Income Historical Data

The historical data trend for NeutriSci International's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeutriSci International Capex-to-Operating-Income Chart

NeutriSci International Annual Data
Trend Mar13 Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NeutriSci International Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NeutriSci International's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, NeutriSci International's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeutriSci International's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NeutriSci International's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where NeutriSci International's Capex-to-Operating-Income falls into.



NeutriSci International Capex-to-Operating-Income Calculation

NeutriSci International's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.004) / -0.508
=N/A

NeutriSci International's Capex-to-Operating-Income for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.069
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeutriSci International  (OTCPK:NRXCF) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


NeutriSci International Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of NeutriSci International's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


NeutriSci International (NeutriSci International) Business Description

Traded in Other Exchanges
Address
1600 - 609 Granville Street, Vancouver, AB, CAN, V7Y 1C3
NeutriSci International Inc is a Canada-based company engaged in the market development of nutraceutical products. The company's revenue consists of sales of the Neueenergy product line.